Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
blueprint medicines
5
×
boston blog main
life sciences
5
×
national blog main
boston top stories
cancer
clinical trials
san francisco blog main
avapritinib
biotech
boston
eli lilly
fda
national top stories
roche
san francisco top stories
cancer drugs
deciphera pharmaceuticals
europe blog main
genentech
indiana blog main
indiana top stories
loxo oncology
medullary thyroid cancer
non-small cell lung cancer
pralsetinib
selpercatinib
thyroid cancer
andrew berens
black diamond therapeutics
bladder cancer
boulder/denver blog main
boulder/denver top stories
capmatinib
companion diagnostic
cstone pharmaceuticals
deals
detroit blog main
detroit top stories
dna sequencing
What
cancer
5
×
drug
fda
approval
blueprint
medicines
genetic
medicine
new
ret
targets
address
announced
approved
approves
biotech
black
candidate
carries
certain
chasing
clinic
companies
currently
deadly
deciphera
deeper
designed
diamond
dna
eluded
filing
fingerprint
forms
gi
going
hopes
ipo
latest
lead
Language
unset
Current search:
cancer
×
" life sciences "
×
" blueprint medicines "
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
4 years ago
Chasing Blueprint, Deciphera Plans FDA Filing for GI Cancer Drug
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues